查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1994299

去除異物器材市場：2026-2032年全球市場預測（依產品類型、入路、治療類型、應用、通路和最終用戶分類）

Foreign Body Removal Device Market by Product Type, Access Route, Procedure Type, Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，去除異物設備市場價值將達到 36.5 億美元，到 2026 年將成長至 39 億美元，到 2032 年將達到 62.6 億美元，複合年成長率為 7.99%。

主要市場統計數據
基準年 2025 36.5億美元
預計年份：2026年 39億美元
預測年份 2032 62.6億美元
複合年成長率 (%) 7.99%

對臨床需求、程序創新和經濟壓力如何改變人們對去除異物裝置的期望進行清晰的背景說明。

從心臟病學到泌尿系統，去除異物裝置在現代微創和影像引導治療中發揮核心作用。該領域已從笨重的一次性器械發展成為功能多樣、精準高效的系統，優先考慮患者安全、手術效率以及與更多入路方式的兼容性。近期技術進步顯著提升了視覺化效果、能量控制和使用者操作體驗，使臨床醫生能夠以更小的創傷和更短的恢復時間處理日益複雜的病例。

影像技術的進步、能量模式的整合以及手術環境的變化如何重新定義產品設計、部署和商業策略。

去除異物器材的市場格局正經歷一場變革，這主要得益於技術、臨床和操作趨勢的融合。首先，影像和導航技術的進步使得更小巧、更精準的器械成為可能，從而減少對周圍組織的損傷，並提高取出成功率。其次，整合影像技術的進一步發展，例如內視鏡可視性的提升和即時透視影像疊加，重新定義了內視鏡和經血管手術的技術可行性範圍。

評估美國關稅調整到 2025 年對供應鏈、採購和商業性公平的多方面營運和策略影響。

美國在2025年前逐步實施的關稅政策，為去除異物設備及其零件供應商帶來了新的挑戰。關稅的影響因醫療設備類型和供應鏈的不同而有所差異，進而影響原料和關鍵子組件（例如成像感測器、精密馬達和特殊合金）的採購選擇。為此，一些製造商正在加速供應商多元化和近岸外包策略，以規避關稅波動對生產計畫的影響，並控制敏感臨床應用的前置作業時間。

一種基於細分市場的、精細的觀點，將產品模式、臨床用途和銷售管道偏好與差異化的開發和商業化重點相結合。

細分市場的趨勢揭示了臨床需求、技術成熟度和購買行為的交匯點，這些因素共同塑造了機會和風險。基於產品類型，本文分析了冷凍消融、電外科、雷射和超音波技術的市場趨勢。冷凍消融術進一步細分為接觸式和非接觸式，電外科細分為雙極式和單極式，雷射細分為二氧化碳雷射、二極體雷射和Nd:YAG雷射，超音波細分為高頻和低頻產品組。每種產品的發展路徑都展現出獨特的特徵。冷凍消融因其在精細解剖區域具有組織保護作用而備受青睞；電外科系統因其在有限空間內的止血效果和快速操作而受到青睞；雷射因其在纖維組織和瘢痕組織中的精準性而備受青睞；超音波技術則能夠在最大限度減少熱擴散的同時實現精準切口。

區域比較分析突顯了監管、醫療服務模式和基礎設施的細微差異如何影響部署和市場進入策略。

不同地區的法規結構、醫療服務模式以及微創醫療設備創新應用率差異顯著。在美洲，實證醫學的應用正在加速推進，這得益於醫療體系優先考慮手術效果、明確的報銷機制以及完善的醫院採購流程。在這種環境下，能夠縮短住院時間並展現可重複臨床效益的醫療設備備受青睞。在歐洲、中東和非洲，由於支付系統和基礎設施的差異，微創醫療器材的應用路徑各不相同。一些市場正在迅速採用先進的內視鏡解決方案，而其他市場則優先考慮成本控制和基本可及性，這需要靈活的服務模式和分階段的產品交付。在亞太地區，對先進手術能力的快速投資以及門診設施的增加，推動了對能夠處理大量患者並滿足不斷變化的監管要求的緊湊型多功能平台的需求。

深入剖析競爭策略，揭示技術合作、模組化設計和差異化服務模式如何重新定義競爭優勢。

去除異物器材領域的競爭趨勢體現在對差異化平台的集中投資、與影像和導航設備供應商的策略合作以及針對性臨床證據的累積。主要企業正投入研發資源，致力於提升器械的易用性、縮短手術時間並拓展其臨床應用範圍，並經常與領先的臨床中心合作，加速迭代式設計改進。同時，一些企業正在探索模組化產品架構，以實現分階段升級並與現有手術系統互通，從而降低醫院和門診的採購門檻。

為製造商和相關人員提供切實可行的策略指導，以推動穩健的產品開發、證據產生和符合實際情況的商業性執行。

產業領導企業應推動一系列切實可行的舉措，將洞察轉化為市場優勢。首先，他們應優先考慮支援多種能量模式和模組化晶片的互通平台設計，以滿足多樣化的臨床需求，並縮短相鄰適應症的研發週期。其次，他們應透過供應商多元化、關鍵零件近岸外包以及建立策略性庫存緩衝來建立具有韌性的供應鏈，從而降低關稅導致的成本和前置作業時間波動風險。第三，他們應投資產生與最終用戶關鍵需求（給藥時間、安全性結果和再處理效率）相符的針對性臨床證據，以便採購委員會能夠清楚地了解其相對價值。

對實證研究途徑進行透明的解釋，該方法結合了文獻綜述、專家訪談和三角驗證，以支持研究結果和建議。

本分析的調查方法結合了系統性的二手資料研究、有針對性的原始資料研究和嚴謹的檢驗。二級資訊來源包括同行評審的臨床文獻、公開的監管文件、技術白皮書和醫療設備使用說明書，這些資料用於確定該技術的基準特徵和臨床性能聲明。原始資料研究包括對循環系統、胃腸科、整形外科和泌尿系統的臨床醫生進行結構化訪談，以及與醫院採購經理、門診手術管理人員和醫療設備工程師進行討論，以了解實際的優先事項和運營限制。

簡潔地總結道，創新、營運韌性和有針對性的商業化決定了哪些解決方案能夠取得持久的臨床和商業性成功。

總之，目前去除異物器材市場正處於操作性創新階段，手術精準度、供應鏈韌性和商業性可行性將決定競爭格局。影像和能量傳輸技術的進步使臨床醫生能夠更安全、更有效率地應對複雜的異物取出挑戰。同時，諸如轉向門診治療和更嚴格的感染控制標準等營運模式的改變正在影響產品需求。到2025年，收費系統趨於穩定，這使得供應鏈的靈活性和成本控制的設計選擇成為持續的挑戰，也使得策略採購和近市場組裝比以往任何時候都更加重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：去除異物設備市場：依產品類型分類

  • 冷凍消融
    • 聯繫類型
    • 非接觸式
  • 用於電外科手術
    • 雙極
    • 單極
  • 雷射
    • CO2
    • 二極體
    • Nd：YAG
  • 超音波
    • 高頻
    • 低頻

第9章：依接取通路分類的去除異物設備市場進入

  • 內視鏡
  • 經皮
  • 血管內

第10章：去除異物設備市場（依處理類型分類）

  • 用於診斷
  • 治療

第11章：去除異物設備市場：依應用領域分類

  • 循環系統
  • 消化系統
  • 整形外科
  • 泌尿系統

第12章：去除異物設備市場：依通路分類

  • 直銷
  • 銷售代理
  • 線上

第13章：去除異物設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第14章：去除異物設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：去除異物設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：去除異物設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國去除異物設備市場

第18章：中國去除異物設備市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Ambu A/S
  • Applied Medical Resources Corporation
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cantel Medical Corporation
  • Coloplast A/S
  • ConMed Corporation
  • Cook Medical Incorporated
  • Endo International plc
  • Fujifilm Holdings Corporation
  • Intuitive Surgical Inc
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Laborie Medical Technologies Inc
  • Medtronic plc
  • Nipro Corporation
  • Olympus Corporation
  • Pentax Medical（HOYA Corporation）
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • STERIS plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-1A1A064C0543

The Foreign Body Removal Device Market was valued at USD 3.65 billion in 2025 and is projected to grow to USD 3.90 billion in 2026, with a CAGR of 7.99%, reaching USD 6.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.65 billion
Estimated Year [2026] USD 3.90 billion
Forecast Year [2032] USD 6.26 billion
CAGR (%) 7.99%

A clear contextual overview of how clinical demand, procedural innovation, and economic pressures are reshaping device expectations in foreign body removal

Foreign body removal devices are central to modern minimally invasive and image-guided interventions, spanning clinical specialties from cardiology to urology. The field has evolved from bulky, single-purpose instruments to versatile, precision-focused systems that emphasize patient safety, procedural efficiency, and compatibility with a broader range of access routes. Recent technological advances have enhanced visualization, energy delivery control, and user ergonomics, enabling clinicians to manage increasingly complex cases with less trauma and shorter recovery times.

Clinicians and procurement teams now evaluate devices not only on technical performance but also on lifecycle economics, sterility profiles, and integration with hospital workflows. With ambulatory surgery centers growing in scope and hospitals prioritizing throughput, device developers must balance reusability with single-use convenience while ensuring regulatory compliance and robust clinical evidence. As a result, product roadmaps are aligning more closely with real-world procedural needs and reimbursement realities.

This introduction frames the subsequent analysis by highlighting the drivers shaping adoption and investment. It emphasizes clinical demand for precision removal across endoscopic, percutaneous, and transvascular routes, the importance of interoperable imaging and navigation, and the competitive necessity for manufacturers to demonstrate clear value through outcomes, ease of use, and total cost of ownership.

How imaging advances, energy modality convergence, and procedural setting shifts are jointly redefining product design, deployment, and commercial strategy

The landscape for foreign body removal devices is undergoing transformative shifts driven by converging technological, clinical, and operational trends. First, imaging and navigation improvements are enabling smaller, more precise instruments that reduce collateral tissue damage and improve retrieval success rates. Advances in integrated imaging, including enhanced endoscopic visualization and real-time fluoroscopic overlays, have redefined what is technically feasible during endoscopic and transvascular procedures.

Second, energy-based modalities are evolving; cryoablation, electrosurgical systems, lasers, and ultrasonic technologies are each becoming more adaptable to hybrid procedural workflows. These modalities are being refined for targeted interaction with foreign materials while preserving surrounding tissue, and innovations in energy control and sensor feedback are improving clinician confidence. Consequently, device designers are focusing on modular platforms that can support multiple energy types or interchangeable tips to address diverse clinical needs.

Third, regulatory focus and infection-prevention priorities are accelerating adoption of disposables and single-use components, yet they coexist with sustainability concerns that push manufacturers to justify reusable platforms through validated reprocessing workflows. Reimbursement pathways and procedural coding updates are also encouraging migration of certain cases to ambulatory settings, affecting device form factors and sterilization expectations. Altogether, these shifts favor solutions that combine procedural precision, streamlined workflows, and demonstrable safety, prompting strategic redirection across the development, commercialization, and service models of device makers.

Assessing the multifaceted operational and strategic consequences of United States tariff adjustments through 2025 on supply chains, sourcing, and commercial parity

The imposition and evolution of tariffs in the United States through 2025 have introduced a new layer of complexity for suppliers of foreign body removal devices and their component ecosystems. Tariff impacts have been heterogeneous across device types and supply chains, influencing the sourcing choices of raw materials and critical subassemblies such as imaging sensors, precision motors, and specialized alloys. In response, some manufacturers have accelerated supplier diversification and nearshoring strategies to insulate production timelines from tariff volatility and to control lead times for sensitive clinical deployments.

Tariff-driven cost pressure has prompted firms to reassess pricing structures and to seek efficiencies through design simplification, consolidation of bill-of-materials, and greater vertical integration of high-risk components. Simultaneously, procurement teams at hospitals and ambulatory centers are more closely scrutinizing total cost implications, opening opportunities for suppliers that can demonstrate cost stability, predictable logistics, and clear clinical value. This dynamic has also heightened interest in modular solutions that enable localized assembly or final configuration, reducing cross-border flows of finished goods subject to duty.

Moreover, tariff policy uncertainty has influenced investment decisions, with some development timelines pushed to accommodate contingency planning and dual-source validation. Regulatory submission pathways and supply documentation requirements have consequently become more prominent considerations during product development, as manufacturers respond to both customs scrutiny and the clinical imperative to maintain uninterrupted device availability.

A nuanced segmentation-driven view that aligns product modalities, clinical applications, and channel preferences with differentiated development and commercialization priorities

Segment-specific dynamics reveal where clinical need, technology readiness, and purchasing behavior intersect to shape opportunity and risk. Based on product type, the landscape is studied across cryoablation, electrosurgical, laser, and ultrasonic technologies; cryoablation is further differentiated into contact and noncontact modalities, electrosurgical into bipolar and monopolar configurations, laser into CO2, diode, and Nd:YAG variants, and ultrasonic into high-frequency and low-frequency offerings. Each product pathway shows distinct trajectories: cryoablation variants are valued for tissue-sparing control in sensitive anatomical sites, electrosurgical systems are prized for haemostasis and speed in constrained workspaces, lasers are selected for precision in fibrotic or scarred tissue, and ultrasonic approaches deliver fine dissection with minimized thermal spread.

Based on application, clinical demand spans cardiovascular, gastrointestinal, orthopedic, and urological procedures, with each therapeutic area prioritizing different performance attributes and access routes. Cardiovascular interventions stress compatibility with transvascular access and intracardiac visualization, gastrointestinal procedures emphasize endoscopic maneuverability and atraumatic grasping, orthopedic cases require robust mechanical interactions for hard-tissue retrieval, and urological applications balance flexibility with irrigation and visibility in confined lumens. Based on end user, adoption patterns differ across ambulatory surgery centers, clinics, and hospitals; ambulatory settings favor compact, cost-efficient solutions that shorten turnover times, clinics emphasize outpatient convenience and workflow simplicity, and hospitals prioritize robust functionality, interoperability with imaging suites, and comprehensive service agreements.

Based on access route, the market is analyzed for endoscopic, percutaneous, and transvascular modalities, where instrument size, visualization, and device durability become critical differentiators. Based on distribution channel, direct, distributor, and online pathways influence go-to-market strategies and after-sales service expectations, shaping the degree of local support and clinical training offered. Based on procedure type, diagnostic and therapeutic workflows impose different regulatory documentation and clinician-training needs, influencing product labeling and commercial emphasis. Taken together, these segmentation lenses clarify where manufacturers should prioritize R&D, clinical studies, and commercialization investments to align with the varied technical and operational requirements across clinical settings and geographies.

Comparative regional analysis highlighting how regulatory nuance, healthcare delivery models, and infrastructure variance shape adoption and go-to-market tactics

Regional dynamics vary considerably in their regulatory frameworks, healthcare delivery models, and adoption velocity for minimally invasive device innovations. In the Americas, there is strong momentum for evidence-based adoption driven by healthcare systems that emphasize procedural outcomes, reimbursement clarity, and robust hospital procurement processes; this environment rewards devices that reduce length of stay and demonstrate reproducible clinical benefits. In Europe, Middle East & Africa, heterogeneity in payer systems and infrastructure creates mixed adoption pathways, with some markets rapidly embracing advanced endoscopic solutions while others prioritize cost containment and basic accessibility, generating a need for adaptable service models and tiered product offerings. In Asia-Pacific, rapid investment in advanced procedural capabilities and growing numbers of ambulatory facilities are increasing demand for compact, versatile platforms that can serve high volumes while meeting evolving regulatory expectations.

Across these regions, regional regulatory nuances, reimbursement timelines, and local manufacturing incentives influence partner selection and go-to-market sequencing. Transitioning between regions requires careful alignment of clinical evidence packages with local standards and a calibrated commercial approach that balances direct engagement with distributor ecosystems. Furthermore, regional supply-chain resilience and logistics capabilities vary, making tariff exposure and inventory planning particularly salient for multinational launches and regional production footprints.

Insight into competitive strategies showing how technology partnerships, modular design, and differentiated service models are redefining competitive advantage

Competitive dynamics in foreign body removal devices are characterized by focused investment in differentiated platforms, strategic partnerships with imaging and navigation providers, and targeted clinical evidence generation. Leading firms are allocating R&D resources to improve usability, reduce procedure time, and expand the clinical envelope of their devices, frequently collaborating with clinical centers of excellence to accelerate iterative design improvements. At the same time, some companies are pursuing modular product architectures that allow for incremental upgrades and cross-compatibility with existing procedural suites, thereby lowering procurement friction for hospitals and ambulatory centers.

Business models are also diversifying: while direct sales remain important for high-touch hospital accounts, distributors and digital channels are gaining traction for commodity components and single-use accessories, offering broader reach for mid-sized suppliers. After-sales services, training programs, and managed maintenance agreements are becoming differentiators that can lock in long-term relationships and reduce total cost concerns for end users. Additionally, merger and acquisition activity and licensing agreements are shaping the competitive field by enabling faster entry into new therapy areas or by securing proprietary technologies, such as advanced imaging sensors or energy-delivery mechanisms.

In this context, companies that combine clinical credibility, dependable supply operations, and flexible commercial models are best positioned to capture sustained clinician preference and institutional adoption.

Actionable strategic guidance for manufacturers and stakeholders to drive resilient product development, evidence generation, and tailored commercial execution

Industry leaders should pursue a pragmatic set of actions to convert insight into market advantage. First, prioritize interoperable platform design that supports multiple energy modalities and modular tips to meet diverse clinical needs while shortening development cycles for adjacent indications. Second, build resilient supply chains through supplier diversification, nearshoring of critical components, and strategic inventory buffers to mitigate tariff-driven cost and lead-time volatility. Third, invest in targeted clinical evidence generation that aligns with key end-user priorities-procedure time, safety outcomes, and reprocessing efficiency-so that procurement committees can clearly see comparative value.

Next, tailor commercialization approaches by region and end-user: offer compact, cost-efficient platforms and streamlined service for ambulatory settings, while providing comprehensive training and integration support for hospital suites. Strengthen distributor and online channel relationships to extend reach for consumables and single-use items, but maintain direct engagement for high-value accounts where clinical training and rapid service response are decisive. Finally, embed sustainability and reprocessing validation where feasible to address environmental concerns without compromising infection prevention. Taken together, these steps create a cohesive approach that aligns product development, regulatory strategy, and commercial execution with evolving clinical and payer expectations.

A transparent description of the evidence-based research approach combining literature review, expert interviews, and triangulation to substantiate insights and recommendations

The research methodology underpinning this analysis combined systematic secondary research with targeted primary inputs and rigorous triangulation. Secondary sources included peer-reviewed clinical literature, publicly available regulatory filings, technical white papers, and device instruction-for-use documentation to establish baseline technology characteristics and clinical performance claims. Primary research incorporated structured interviews with practicing clinicians across cardiovascular, gastrointestinal, orthopedic, and urological specialties, as well as discussions with hospital procurement leaders, ambulatory surgery administrators, and device engineers to capture real-world priorities and operational constraints.

Data synthesis followed a triangulation approach, reconciling insights from literature, expert interviews, and device specifications to ensure consistency and to surface divergent perspectives. The analysis evaluated product pipelines, access-route preferences, and distribution channel behavior through an evidence-first lens, emphasizing reproducibility and contextual validation. Quality controls included source verification, cross-referencing of clinical claims with procedural guidelines, and sensitivity checks around supply-chain and tariff-related scenarios to ensure the resulting recommendations are robust and practically actionable for decision-makers.

A concise synthesis emphasizing how innovation, operational resilience, and targeted commercialization will determine which solutions achieve durable clinical and commercial success

In conclusion, the foreign body removal device landscape is experiencing a period of pragmatic innovation where procedural precision, supply-chain resilience, and commercial adaptability determine competitive outcomes. Technological advances in imaging and energy delivery are enabling clinicians to tackle complex retrieval challenges with greater safety and efficiency, while operational shifts toward ambulatory care and heightened infection-prevention standards are altering product requirements. Tariff dynamics through 2025 have introduced a persistent need for supply-chain agility and cost-conscious design choices, making strategic sourcing and near-market assembly more relevant than ever.

Manufacturers that align modular design, focused clinical evidence, and regionally calibrated commercialization models will be best placed to meet diverse end-user needs and to reduce procurement friction. Equally, companies that couple robust after-sales support with effective training programs can secure preference in high-touch hospital environments and expand adoption in ambulatory settings. Ultimately, the intersection of clinical performance, operational reliability, and commercial clarity will determine which solutions succeed in delivering consistent clinical outcomes and sustained institutional adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Foreign Body Removal Device Market, by Product Type

  • 8.1. Cryoablation
    • 8.1.1. Contact
    • 8.1.2. Noncontact
  • 8.2. Electrosurgical
    • 8.2.1. Bipolar
    • 8.2.2. Monopolar
  • 8.3. Laser
    • 8.3.1. CO2
    • 8.3.2. Diode
    • 8.3.3. Nd:YAG
  • 8.4. Ultrasonic
    • 8.4.1. High-Frequency
    • 8.4.2. Low-Frequency

9. Foreign Body Removal Device Market, by Access Route

  • 9.1. Endoscopic
  • 9.2. Percutaneous
  • 9.3. Transvascular

10. Foreign Body Removal Device Market, by Procedure Type

  • 10.1. Diagnostic
  • 10.2. Therapeutic

11. Foreign Body Removal Device Market, by Application

  • 11.1. Cardiovascular
  • 11.2. Gastrointestinal
  • 11.3. Orthopedic
  • 11.4. Urological

12. Foreign Body Removal Device Market, by Distribution Channel

  • 12.1. Direct
  • 12.2. Distributor
  • 12.3. Online

13. Foreign Body Removal Device Market, by End User

  • 13.1. Ambulatory Surgery Centers
  • 13.2. Clinics
  • 13.3. Hospitals

14. Foreign Body Removal Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Foreign Body Removal Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Foreign Body Removal Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Foreign Body Removal Device Market

18. China Foreign Body Removal Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Ambu A/S
  • 19.7. Applied Medical Resources Corporation
  • 19.8. Becton Dickinson and Company
  • 19.9. Boston Scientific Corporation
  • 19.10. Cantel Medical Corporation
  • 19.11. Coloplast A/S
  • 19.12. ConMed Corporation
  • 19.13. Cook Medical Incorporated
  • 19.14. Endo International plc
  • 19.15. Fujifilm Holdings Corporation
  • 19.16. Intuitive Surgical Inc
  • 19.17. Johnson & Johnson
  • 19.18. Karl Storz SE & Co. KG
  • 19.19. Laborie Medical Technologies Inc
  • 19.20. Medtronic plc
  • 19.21. Nipro Corporation
  • 19.22. Olympus Corporation
  • 19.23. Pentax Medical (HOYA Corporation)
  • 19.24. Richard Wolf GmbH
  • 19.25. Smith & Nephew plc
  • 19.26. STERIS plc
  • 19.27. Stryker Corporation
  • 19.28. Teleflex Incorporated
  • 19.29. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CONTACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CONTACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CONTACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY NONCONTACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY NONCONTACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY NONCONTACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY BIPOLAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY BIPOLAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY BIPOLAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY MONOPOLAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY MONOPOLAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY MONOPOLAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CO2, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CO2, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CO2, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIODE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIODE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIODE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ND:YAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ND:YAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ND:YAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HIGH-FREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HIGH-FREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HIGH-FREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LOW-FREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LOW-FREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LOW-FREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PERCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PERCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY TRANSVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY TRANSVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY TRANSVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 200. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 201. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 202. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 203. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. GCC FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 233. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 234. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 235. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 236. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 237. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. G7 FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 244. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 245. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 246. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 247. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 248. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. NATO FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY CRYOABLATION, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ELECTROSURGICAL, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ULTRASONIC, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA FOREIGN BODY REMOVAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)